D-1059-2014 Class III Terminated
FDA drug recall D-1059-2014 was initiated by Greenstone Llc on Nov 4, 2013 and is designated Class III. Reason for recall: Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval The recall status is terminated (terminated Jun 24, 2015). Affected quantity: 22,529 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 12, 2014
- Initiation Date
- Nov 4, 2013
- Termination Date
- Jun 24, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 22,529 bottles
Product description
Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2
Reason for recall
Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval
Distribution pattern
US Nationwide (including PR)
Code information
lot V112000, EXP Jun 2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1059-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026